STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma

MLA

John V. Heymach, et al. “STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.” Cancer Discovery, vol. 8, July 2018, pp. 822–35. EBSCOhost, https://doi.org/10.1158/2159-8290.cd-18-0099.

APA

John V. Heymach, Michael E. Goldberg, Niamh Long, Darragh Halpenny, Neelesh Sharma, William J. Geese, Jennifer L. Sauter, David R. Spigel, Ignacio I. Wistuba, Gaurav Singal, Jose A. Bufill, Alexa B. Schrock, Andrew J. Plodkowski, Roxana Azimi, Jaime Rodriguez-Canales, Neda Kalhor, Lee A. Albacker, Pan Tong, Mari Mino-Kenudson, … Ana Galan-Cobo. (2018). STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma. Cancer Discovery, 8, 822–835. https://doi.org/10.1158/2159-8290.cd-18-0099

Chicago

John V. Heymach, Michael E. Goldberg, Niamh Long, Darragh Halpenny, Neelesh Sharma, William J. Geese, Jennifer L. Sauter, et al. 2018. “STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.” Cancer Discovery 8 (July): 822–35. doi:10.1158/2159-8290.cd-18-0099.